• Search History (Register)
  • MeSH Browser
  • [Clear]
    • English

Welcome to the international HTA database


Showing [16861 Records] Selected Records [0 Hits] [Clear]
Year Source Title
2010     NIHR Health Technology Assessment programme Aripiprazole for the treatment of schizophrenia in adolescents (aged 15-17 years)
2010     Medical Advisory Secretariat (MAS) Robotic-assisted minimally invasive surgery for gynecologic and urologic oncology: an evidence-based analysis
2010     Agenzia sanitaria e sociale regionale, Regione Emilia-Romagna (ASSR) Medical device for intravesical microwave hyperthermia in the treatment of superficial bladder cancer
2010     NIHR Health Technology Assessment programme Gefitinib for the first-line treatment of locally advanced or metastatic non-small cell lung cancer
2010     Medical Advisory Secretariat (MAS) Non-invasive cardiac imaging technologies for the assessment of myocardial viability
2010     NIHR Health Technology Assessment programme Golimumab for the treatment of rheumatoid arthritis after failure of previous disease-modifying antirheumatic drugs: a single technology appraisal
2010     NIHR Health Technology Assessment programme School-linked sexual health services for young people (SSHYP): a survey and systematic review concerning current models, effectiveness, cost-effectiveness and research opportunities
2010     NIHR Health Technology Assessment programme Pazopanib for the first line treatment of patients with advanced and/or metastatic renal cell carcinoma: a single technology appraisal
2010     NIHR Health Technology Assessment programme Group cognitive behavioural therapy for postnatal depression: a systematic review of clinical effectiveness, cost effectiveness and value of information analyses
2010     NIHR Health Technology Assessment programme Vinflunine for the second line treatment of transitional cell carcinoma of the urothelial tract
2010     NIHR Health Technology Assessment programme Rituximab for the first-line maintenance treatment of follicular non-Hodgkin's lymphoma
2010     NIHR Health Technology Assessment programme Clinical effectiveness and cost-effectiveness of continuous subcutaneous insulin infusion for diabetes: systematic review and economic evaluation
2010     NIHR Health Technology Assessment programme Early referral strategies for management of people with markers of renal disease: a systematic review of the evidence of clinical effectiveness, costeffectiveness and economic analysis
2010     NIHR Health Technology Assessment programme Chemoprevention of colorectal cancer: systematic review and economic model
2010     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Ranolazine (Ranexa®)
2010     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Atazanavir (Reyataz®) capsules
2010     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Sildenafil citrate (Revatio®) solution
2010     Blue Cross Blue Shield Association (BCBS) Gene expression profiling in women with lymph-node-positive breast cancer to select adjuvant chemotherapy treatment
2010     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Tipranavir (Aptivus®) capsules
2010     Blue Cross Blue Shield Association (BCBS) Wearable cardioverter-defibrillator as a bridge to implantable cardioverter-defibrillator treatment
2010     HAYES, Inc. Alair bronchial thermoplasty system (Asthmatx Inc.) for treatment of asthma
2010     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Tipranavir (Aptivus®) oral solution
2010     Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) [Bariatric surgery in diabetic type 2 patients with CMI at or above 30 kg/m2]
2010     Blue Cross Blue Shield Association (BCBS) Special report: positron emission tomography for the indication of post-treatment surveillance of cancer
2010     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Epoetin theta (Eporatio®)
2010     Blue Cross Blue Shield Association (BCBS) Low-level laser therapy for carpal tunnel syndrome and chronic neck pain
2010     HAYES, Inc. Autologous stem cell transplantation followed by nonmyeloablative allogeneic stem cell transplantation for treatment of multiple myeloma
2010     Blue Cross Blue Shield Association (BCBS) Radiofrequency ablation of nondysplastic or low-grade dysplastic barrett's esophagus
2010     Penn Medicine Center for Evidence-based Practice (CEP) Postpartum management of hypertensive disorders
2010     HAYES, Inc. Bayley scales of infant (and toddler) development testing (Pearson Education Inc.) for developmental delays in infants
2010     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Olanzapine depot (ZypAdhera)
2010     The Swedish Council on Health Technology Assessment (SBU) Antibiotic prophylaxis in surgical interventions
2010     Penn Medicine Center for Evidence-based Practice (CEP) Calibration of computerized drug interaction alerts
2010     Penn Medicine Center for Evidence-based Practice (CEP) Albumin use in the healthcare setting
2010     HAYES, Inc. Brainstem Auditory Evoked Response (BAER) for assessment of brainstem dysfunction in patients with chiari malformations
2010     VA Technology Assessment Program (VATAP) Gadolinium-containing contrast agents for patients with renal disease
2010     Penn Medicine Center for Evidence-based Practice (CEP) Prevention of catheter-associated venous thrombosis
2010     HAYES, Inc. Breast-Specific Gamma Imaging (BSGI) using the Dilon 6800 gamma camera (Dilon Technologies Inc.)
2010     Penn Medicine Center for Evidence-based Practice (CEP) Routine newborn monitoring immediately following birth
2010     HAYES, Inc. Chantix (Varenicline Tartrate) (Pfizer Inc.) for smoking cessation
2010     Penn Medicine Center for Evidence-based Practice (CEP) Pre-operative hair removal in different settings to decrease surgical site infections
2010     HAYES, Inc. ChloraPrep (CareFusion Corp.) for skin antisepsis
2010     Penn Medicine Center for Evidence-based Practice (CEP) Preventing catheter-related bloodstream infections in home infusion patients
2010     Penn Medicine Center for Evidence-based Practice (CEP) Care management
2010     Penn Medicine Center for Evidence-based Practice (CEP) Permacol implants for hernia repair
2010     Penn Medicine Center for Evidence-based Practice (CEP) Adapting Penn Medicine's inpatient services to meet the ACGME's proposed duty hour regulations
2010     HAYES, Inc. Entereg (Alvimopan) (Adolor Corp.) to reduce postoperative ileus
2010     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Cetuximab (Erbitux®) for third-line treatment of patients with KRAS wild-type metastatic colorectal cancer
2010     Penn Medicine Center for Evidence-based Practice (CEP) Management of retroperitoneal bleeding in coronary catheterization patients
2010     Penn Medicine Center for Evidence-based Practice (CEP) Management of central venous catheters in hemodialysis patients with bloodstream infections
2010     HAYES, Inc. E-tegrity test (Hologic Inc.; distributed by Sepal Reproductive Devices) for evaluation of uterine receptivity
2010     Penn Medicine Center for Evidence-based Practice (CEP) Guidelines for care after percutaneous coronary intervention (PCI)
2010     Penn Medicine Center for Evidence-based Practice (CEP) Guidelines for warfarin use in orthopedic surgery patients
2010     HAYES, Inc. HE4 assay (Fujirebio Diagnostics Inc.) on the Architect platform (Abbott Diagnostics) for ovarian cancer monitoring
2010     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Epoetin alfa (Binocrit®)
2010     Penn Medicine Center for Evidence-based Practice (CEP) Transfusion thresholds for orthopedic surgery patients
2010     Penn Medicine Center for Evidence-based Practice (CEP) Silver coated dressings for prevention of surgical site infections in cardiac surgery patients
2010     HAYES, Inc. Inhaled nitric oxide for Acute Respiratory Distress Syndrome (ARDS) in adults
2010     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Filgrastim (TevaGrastim®)
2010     Penn Medicine Center for Evidence-based Practice (CEP) Dexmedetomidine for sedation during intubation
2010     Penn Medicine Center for Evidence-based Practice (CEP) GI bleeding risks with celecoxib
2010     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Filgrastim (Zarzio®)
2010     Penn Medicine Center for Evidence-based Practice (CEP) Management of the second stage of labor
2010     Quality Improvement Scotland (NHS QIS ) A guide to synthesising qualitative research for researchers undertaking health technology assessments and systematic reviews
2010     Penn Medicine Center for Evidence-based Practice (CEP) CT for acute chest pain
2010     HAYES, Inc. Intraoperative Radiation Therapy (IORT) for colorectal cancer
2010     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Sildenafil (Revatio®) for the treatment of pulmonary arterial hypertension (WHO functional class II or III) to improve exercise capacity
2010     Penn Medicine Center for Evidence-based Practice (CEP) Transfusion thresholds for cardiovascular surgery patients
2010     Quality Improvement Scotland (NHS QIS ) Weight management programmes for adults
2010     Penn Medicine Center for Evidence-based Practice (CEP) Bleeding risks from celecoxib vs. non-selective NSAIDS in orthopedic surgery
2010     HAYES, Inc. Intraoperative Radiation Therapy (IORT) for pancreatic cancer
2010     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Raltegravir (Isentress®) in combination with other antiretrovirals for the treatment of HIV-1 infection in adults
2010     Penn Medicine Center for Evidence-based Practice (CEP) Urine drug screening in chronic pain patients on opioid therapy
2010     Quality Improvement Scotland (NHS QIS ) Portable bladder ultrasound scanners
2010     Penn Medicine Center for Evidence-based Practice (CEP) The use of bispectral index monitoring for patients receving therapeutic hypothermia
2010     Penn Medicine Center for Evidence-based Practice (CEP) Controlled medication agreements for opioid use in chronic pain
2010     Quality Improvement Scotland (NHS QIS ) Bariatric surgery in adults
2010     Penn Medicine Center for Evidence-based Practice (CEP) The effect of the timing of cardiac catheterization prior to cardiac surgery on post-operative renal outcomes
2010     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Pramipexole prolonged release tablets (Mirapexin®)
2010     Penn Medicine Center for Evidence-based Practice (CEP) Use of opioids for treatment of fibromyalgia
2010     Medical Advisory Secretariat (MAS) Neuroimaging for the evaluation of chronic headaches : an evidence-based analysis
2010     Quality Improvement Scotland (NHS QIS ) Topical negative pressure therapy for wounds
2010     Penn Medicine Center for Evidence-based Practice (CEP) Vertos mild for lumbar decompression
2010     HAYES, Inc. Intravenous lidocaine infusion for neuropathic pain
2010     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Epoetin zeta (Retacrit®)
2010     Penn Medicine Center for Evidence-based Practice (CEP) Use of opioids for treating chronic back pain
2010     Medical Advisory Secretariat (MAS) Balloon kyphoplasty for treatment of painful osteoporotic vertebral compression fractures : an evidence update
2010     Quality Improvement Scotland (NHS QIS ) Extracorporeal membrane oxygenation (ECMO) for respiratory support in adults
2010     Penn Medicine Center for Evidence-based Practice (CEP) Comparative effectiveness of torsemide for edema in hospitalized heart failure patients
2010     HAYES, Inc. Laminotomy for lumbar spinal stenosis
2010     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Fentanyl (Instanyl®)
2010     Penn Medicine Center for Evidence-based Practice (CEP) Annotated search: clinical trials of dexmedetomidine in surgery and other invasive procedures
2010     Penn Medicine Center for Evidence-based Practice (CEP) Antimicrobial sutures for prevention of surgical infections
2010     HAYES, Inc. Laparoscopic exploration of the contralateral groin during repair of pediatric inguinal hernia
2010     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Enoxaparin (Clexane®)
2010     Penn Medicine Center for Evidence-based Practice (CEP) Electrosurgical smoke
2010     HAYES, Inc. Laparoscopic sleeve gastrectomy for super obesity in adults
2010     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Paclitaxel albumin (Abraxane®)
2010     Penn Medicine Center for Evidence-based Practice (CEP) Dexmedetomidine for sedation of non-surgical patients
2010     Agency for Healthcare Research and Quality (AHRQ) Management of acute otitis media: update